Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes - Cardiovascular Diabetology

Retrieved on: 2025-03-29 13:09:04

Tags for this article:

Click the tags to see associated articles and topics

Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes - Cardiovascular Diabetology. View article details on hiswai:

Excerpt

To evaluate the efficacy of anti-CD3 monoclonal antibody (mAb) in patients with type 1 diabetes (T1D) and identify the influencing factors.

Article found on: cardiab.biomedcentral.com